These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21819556)

  • 1. A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.
    Heckmann JM; Rawoot A; Bateman K; Renison R; Badri M
    BMC Neurol; 2011 Aug; 11():97. PubMed ID: 21819556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in generalized myasthenia gravis: a systematic review.
    Prado MB; Adiao KJB
    Acta Neurol Belg; 2023 Oct; 123(5):1679-1691. PubMed ID: 36967437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
    Pasnoor M; He J; Herbelin L; Burns TM; Nations S; Bril V; Wang AK; Elsheikh BH; Kissel JT; Saperstein D; Shaibani JA; Jackson C; Swenson A; Howard JF; Goyal N; David W; Wicklund M; Pulley M; Becker M; Mozaffar T; Benatar M; Pazcuzzi R; Simpson E; Rosenfeld J; Dimachkie MM; Statland JM; Barohn RJ;
    Neurology; 2016 Jul; 87(1):57-64. PubMed ID: 27306628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study.
    Rodolico C; Bonanno C; Brizzi T; Nicocia G; Trimarchi G; Lupica A; Pugliese A; Musumeci O; Toscano A
    J Clin Neuromuscul Dis; 2021 Dec; 23(2):61-65. PubMed ID: 34808648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis.
    Di L; Shen F; Wen X; Lu Y; Zhu W; Wang M; Da Y
    Front Immunol; 2022; 13():839075. PubMed ID: 35371086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis.
    Kaymaz-Tahra S; Bayindir O; Ince B; Ozdemir İsik O; Kutu ME; Karakas O; Yildirim TD; Ademoglu Z; Ediboglu ED; Uludogan BCE; Ilgin C; Bilge NSY; Kasifoglu T; Akar S; Emmungil H; Onen F; Omma A; Kanitez NA; Yazici A; Cefle A; Inanc M; Aksu K; Keser G; Direskeneli H; Alibaz-Oner F
    Semin Arthritis Rheum; 2024 Jun; 66():152446. PubMed ID: 38669786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.
    Dodd KC; Ahmed R; Ambrose P; Holt JK; Jacob S; Leite MI; Miller JA; San PP; Spillane J; Viegas S; Sussman J
    Neuromuscul Disord; 2024 May; 38():51-57. PubMed ID: 38626662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognosis of myasthenia gravis in older people.
    Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
    J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
    Nosadini M; Mohammad SS; Toldo I; Sartori S; Dale RC
    Eur J Paediatr Neurol; 2019 Jan; 23(1):7-18. PubMed ID: 30318435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.
    Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Mulder J; Rasker JJ; Kruijsen MW; Haverman JF; van Beusekom HJ; Muller WH
    Arthritis Rheum; 1991 Aug; 34(8):961-72. PubMed ID: 1859490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
    Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
    J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis.
    Wendt T; Eidner T; Bräunig E; Hein G
    Eur J Med Res; 1999 Oct; 4(10):442-8. PubMed ID: 10527958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study.
    Milanesi A; Delvino P; Quaglini S; Montecucco C; Monti S
    Rheumatology (Oxford); 2024 Apr; 63(4):945-952. PubMed ID: 37326880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of methotrexate in myasthenia gravis.
    Pasnoor M; He J; Herbelin L; Dimachkie M; Barohn RJ;
    Ann N Y Acad Sci; 2012 Dec; 1275(1):23-8. PubMed ID: 23278574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial.
    Sharshar T; Porcher R; Demeret S; Tranchant C; Gueguen A; Eymard B; Nadaj-Pakleza A; Spinazzi M; Grimaldi L; Birnbaum S; Friedman D; Clair B;
    JAMA Neurol; 2021 Apr; 78(4):426-433. PubMed ID: 33555314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
    Paoluzi OA; Pica R; Marcheggiano A; Crispino P; Iacopini F; Iannoni C; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1751-9. PubMed ID: 12269968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial of Thymectomy in Myasthenia Gravis.
    Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
    N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.